Role of Bcl-2 and Ki67 in endometrial lesions
Not Applicable
- Conditions
- Health Condition 1: C541- Malignant neoplasm of endometrium
- Registration Number
- CTRI/2024/02/062918
- Lead Sponsor
- Pragya chitravanshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All histopathologically confirmed cases of non neoplastic and neoplastic endometrial lesions.
Exclusion Criteria
Patients who are on hormonal therapy
Biopsies diagnosed as the product of conception
Biopsies that are unsatisfactory
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To classify non neoplastic and neoplastic endometrial lesions on the basis of histomorphology. <br/ ><br>To evaluate Bcl-2 and Ki-67 expression in non-neoplastic and neoplastic endometrial lesions. <br/ ><br>To correlate Bcl-2 with Ki-67 expression in these lesionsTimepoint: Monthly
- Secondary Outcome Measures
Name Time Method To classify non neoplastic & neoplastic endometrial lesions on the basis of histomorphology. <br/ ><br> <br/ ><br>To evaluate Bcl-2 & Ki-67 expression in non-neoplastic & neoplastic endometrial lesions. <br/ ><br> <br/ ><br>To correlate Bcl-2 with Ki-67 expression in these lesionsTimepoint: 4 weeks